Thoracic-Lumbar Arthrodesis- Implanet Jazz
Launched by FRANCIS FARHADI · May 4, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new system called the Implanet Jazz System, which is used during a specific type of back surgery called lumbar arthrodesis. This surgery is often recommended for conditions like spondylolisthesis, spinal stenosis, and degenerative disease, which can cause pain and discomfort in the lower back. The goal of the trial is to collect information from patients who have had this surgery to better understand how well the Implanet Jazz System works.
To participate in this trial, you should be at least 18 years old and a good candidate for the surgery with the Implanet Jazz System. The study is currently looking for both men and women who meet these criteria. If you decide to join, you can expect to be part of a group that helps researchers gather valuable data about this surgery and its outcomes for patients. It's important to note that this trial is still recruiting participants, so there’s an opportunity to contribute to important research in spinal health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male and female patients, 18 years of age and older
- • Qualified candidate for hybrid thoracolumbar fixation with the Implanet Jazz System TM during arthrodesis surgery.
- Exclusion Criteria:
- • Individuals who have not yet reached the age of 18.
About Francis Farhadi
Francis Farhadi is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on conducting rigorous and ethically sound studies, the organization emphasizes collaboration with healthcare professionals and institutions to develop effective therapies and improve patient outcomes. Leveraging a wealth of expertise in clinical trial management, Francis Farhadi ensures adherence to regulatory standards and best practices, fostering an environment of transparency and accountability. Through their initiatives, they aim to contribute significantly to the scientific community and enhance the quality of care across various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lexington, Kentucky, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials